|Printable version||E-mail this to a friend|
Cancer Research UK - 1 in 5 emergency bowel cancer patients had symptoms before diagnosis
Around one in five bowel cancer patients diagnosed after an emergency presentation have displayed at least one cancer ‘alarm symptom’ in the year leading up to their diagnosis, according to a Cancer Research UK-funded study (link is external) published in the British Journal of Cancer (link is external).
The study found that ‘red flag’ symptoms were much more common in patients who were diagnosed via non-emergency routes, and that patients diagnosed as an emergency often did not display these symptoms strongly associated with bowel cancer.
It’s lack of these ‘red flag’ symptoms in many patients diagnosed as an emergency that makes it much more difficult for GPs to diagnose the cancer early.
But a proportion of patients - 17.5 per cent of colon cancer patients and 23 per cent of rectal cancer patients diagnosed as an emergency – had ‘red flag’ symptoms, indicating there could have been opportunities to pick up the disease earlier.
Most patients, regardless of how they were diagnosed, visited their doctor in the year before their diagnosis. And patients saw their doctors more often in the months and days leading up to their diagnosis, with the number of visits increasing significantly both for patients diagnosed by emergency and non-emergency routes.
The study, at University College London (link is external) and the London School of Hygiene & Tropical Medicine (link is external), looked at National Cancer Registry data that was linked to GP data for 1,606 patients across more than 200 GP practices. The research focused on patient data for the five years leading up to the cancer diagnosis.
Cristina Renzi, lead researcher, Cancer Research UK scientist at University College London, said: “We know that patients diagnosed with cancer after emergency presentations don’t do as well as patients who are diagnosed by their doctor through non-emergency routes. This study shows that most patients – who are picked up through the emergency route - can be harder to diagnose as they often don’t show typical bowel cancer symptoms. However, in most cases they visit their doctor for various reasons multiple times during the months leading up to their diagnosis, which could represent opportunities to diagnose the cancer earlier.
“It’s important to find ways to ensure these patients can be diagnosed at an early stage. And this study highlights the need to support GPs and give them the tools to diagnose and refer patients promptly when they feel it’s necessary.”
Dr Julie Sharp, Cancer Research UK’s head of patient information and health, said: “This research shows the difficulties in diagnosing patients who are not showing typical symptoms of bowel cancer. In some cases where people have been diagnosed after an emergency presentation, there may have been opportunities for people to be diagnosed earlier, and it’s important to try to find better ways of picking up these patients and getting them referred appropriately.
“So research like this, to understand more about people’s symptom histories, is crucial to find better ways to diagnose the disease at an early stage when treatment is more likely to be successful.”
For media enquiries please contact the Cancer Research UK press office on +44 203 469 8300 or, out-of-hours, the duty press officer on +44 7050 264 059.
Renzi et al., Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England. British Journal of Cancer, 2016.
Latest News from
Cancer Research UK - Trial to test for Barrett’s oesophagus launches in GP surgeries across the UK28/03/2017 11:35:00
A Cancer Research UK-funded trial allowing GP surgeries to test for Barrett’s oesophagus – a condition that can increase the risk of developing oesophageal cancer – launches in the UK today.
Cancer Research UK - New era in precision medicine for pancreatic cancer27/03/2017 08:10:00
The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK.
Age UK responds to the Cridland Review25/03/2017 09:15:00
Age UK responds to the Cridland Review – State Pension Age needs to increase from 67 to 68 by 2039 together with new help from those most affected.
Cancer Research UK - Global smoking rates have fallen since introduction of international tobacco control strategy23/03/2017 14:35:00
Smoking rates have fallen globally since the World Health Organisation (WHO) introduced a treaty aimed at reducing tobacco demand, according to a new study.